4th Mar 2008 07:00
For immediate release 4th March 2008 LiDCO Group Plc ("LiDCO" or the "Company") LiDCOrapid Preview at World Congress & Investor Day
LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, announces that the Company's new product the LiDCOrapid Monitor, is being exhibited to customers for the first time at the 14th World Congress of Anaesthesiologists being held in Cape Town, South Africa from 2 to 7 March 2008.
This is first major international meeting where the LiDCOrapid product will be displayed. Supporting the product at the meeting will be a paper outlining the design concept and role in the management of risk surgery patients and a presentation from use of the product in surgery. Both the paper and presentation will be available on request from LiDCO.
Dr Terry O'Brien, CEO LiDCO Group commented:
"We are on track to release the LiDCOrapid Monitor for sale on time and as expected in the first quarter of our financial year. Feedback from the clinical user group in both the UK and USA has been excellent and highly supportive for the product's commercial potential. Our direct sales staff and distributors are excited that they will be able to sell this new surgery product in the very near future."
* ENDS -
Note for investors: LiDCO are holding an investor day at their facility in London on the 5th of March - where both the existing products and the new LiDCOrapid and LiDCOviewPRO will be on display. Investors who would like to attend please contact the Company - see below.
For more information please contact:
LiDCO Group Plc Tel: +44 (0)20 7749 1500
Terry O'Brien - Chief Executive
John Rowland - Company Secretary
Buchanan Communications Tel: +44 (0)20 7466 5000
Tim Anderson, James StrongNotes for EditorsAbout LiDCO Group Plc
LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. For more information please see www.lidco.com.
The Company's manufacturing facility is in Hoxton, London and its current products are:
* LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume (PPV% and SVV%).
* LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.
* LiDCOview is designed as a graphical display of historical LiDCOplus hemodynamic data. LiDCOview provides both the clinical researcher and the routine user with easy to view beat-to-beat hemodynamic data that was collected with the LiDCOplus.. LiDCOviewSE is the standard version of this tool and is available for free, allowing anyone to download and access data from the LiDCOplus. LiDCOviewPRO is the Professional version, allowing users to analyse, export and report the LiDCOplus data. A free trial of LiDCOviewPRO is available for evaluation purposes prior to purchase.
* LiDCOlive - software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus monitor.
Distribution Network:
The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of speciality critical care and anesthesia distributors.
LIDCO GROUP PLCRelated Shares:
LID.L